[1]廖丽娟.阿托伐他汀钙片、阿司匹林肠溶片与胞磷胆碱片联合治疗脑梗死的临床疗效及对总胆固醇水平的影响[J].医学信息,2024,37(20):108-111.[doi:10.3969/j.issn.1006-1959.2024.20.021]
　LIAO Lijuan.Clinical Efficacy of Atorvastatin Calcium Tablets, Aspirin Enteric-coated Tablets Combined with Citicoline Tablets in the Treatment of Cerebral Infarction and its Effect on Total Cholesterol Level[J].Journal of Medical Information,2024,37(20):108-111.[doi:10.3969/j.issn.1006-1959.2024.20.021]
点击复制

阿托伐他汀钙片、阿司匹林肠溶片与胞磷胆碱片联合治疗脑梗死的临床疗效及对总胆固醇水平的影响()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
37卷
期数:
2024年20期
页码:
108-111
栏目:
论著
出版日期:
2024-10-15

文章信息/Info

Title:
Clinical Efficacy of Atorvastatin Calcium Tablets, Aspirin Enteric-coated Tablets Combined with Citicoline Tablets in the Treatment of Cerebral Infarction and its Effect on Total Cholesterol Level
文章编号:
1006-1959（2024）20-0108-04
作者:
廖丽娟
龙南市第一人民医院住院部药房，江西 龙南 341700
Author(s):
LIAO Lijuan
Department of Inpatient Pharmacy,Longnan First People’s Hospital,Longnan 341700,Jiangxi,China
关键词:
脑梗死; 阿托伐他汀钙片; 阿司匹林肠溶片; 胞磷胆碱片; 总胆固醇
Keywords:
Cerebral infarction; Atorvastatin calcium tablets; Aspirin enteric-coated tablets; Cytidine tablets; Total cholesterol
分类号:
R743.3
DOI:
10.3969/j.issn.1006-1959.2024.20.021
摘要:
目的 研究阿托伐他汀钙片（AC）、阿司匹林肠溶片（ASA）联合胞磷胆碱片治疗脑梗死的临床疗效及对总胆固醇水平的影响。方法 纳入2020年6月-2023年6月龙南市第一人民医院收治的60例脑梗死患者，行随机数字表法分为对照组（30例）与观察组（30例），对照组给予AC+ASA治疗，观察组在其基础上联合胞磷胆碱片治疗，比较两组临床疗效、美国国立卫生研究院卒中量表评分（NIHSS）、改良Barthel指数（MBI）、血脂水平[总胆固醇（TC）、三酰甘油（TG）、高密度脂蛋白（HDL-C）、低密度脂蛋白（LDL-C）]、不良反应、复发情况。结果 观察组治疗优良率（90.00%）高于对照组（66.67%）（P＜0.05）；两组治疗后NIHSS分数下降，MBI分数升高，且观察组NIHSS分数低于对照组，MBI分数高于对照组（P＜0.05）；两组治疗后TC、TG、LDL-C指标降低，HDL-C指标升高，且观察组TC、TG、LDL-C指标低于对照组，HDL-C指标高于对照组（P＜0.05）；两组不良反应发生率比较，差异无统计学意义（P＞0.05）；观察组复发率低于对照组（P＜0.05）。结论 AC、ASA与胞磷胆碱片联合应用可提高脑梗死治疗效果，改善患者神经功能，调节其总胆固醇等血脂水平，降低复发风险，且具有较高用药安全性。
Abstract:
Objective To study the clinical efficacy of atorvastatin calcium tablets (AC), aspirin enteric-coated tablets (ASA) combined with citicoline tablets in the treatment of cerebral infarction and its effect on total cholesterol level.Methods Sixty patients with cerebral infarction admitted to Longnan First People’s Hospital from June 2020 to June 2023 were randomly divided into control group (30 patients) and observation group (30 patients). The control group was treated with AC+ASA, and the observation group was treated with citicoline tablets on the basis of the control group. The clinical efficacy, National Institutes of Health Stroke Scale score (NIHSS), modified Barthel index (MBI), blood lipid levels [total cholesterol (TC), triglyceride (TG), high density lipoprotein (HDL-C), low density lipoprotein (LDL-C)], adverse reactions and recurrence were compared between the two groups.Results The excellent and good rate of treatment in the observation group (90.00%) was higher than that in the control group ( 66.67%) (P<0.05). After treatment, the NIHSS score of the two groups decreased and the MBI score increased, and the NIHSS score of the observation group was lower than that of the control group, and the MBI score was higher than that of the control group (P<0.05). After treatment, the TC, TG and LDL-C indexes of the two groups decreased, the HDL-C index increased, and the TC, TG and LDL-C indexes of the observation group were lower than those of the control group, the HDL-C index was higher than that of the control group (P<0.05). There was no significant difference in the incidence of adverse reactions between the two groups (P>0.05). The recurrence rate of the observation group was lower than that of the control group (P<0.05).Conclusion The combined application of AC, ASA and citicoline tablets can improve the therapeutic effect dor patients with cerebral infarction, improve the neurological function, regulate the blood lipid levels such as total cholesterol, reduce the risk of recurrence, and has high drug safety.

参考文献/References:

[1]高梦霞,阎明源,王海若,等.氯吡格雷联合阿托伐他汀对脑梗死患者炎症反应、血液流变学和凝血功能影响的系统评价[J].中国医院用药评价与分析,2022,22(5):595-602.[2]单文清.阿司匹林肠溶片联合阿托伐他汀钙片治疗脑血栓临床效果分析[J].山西医药杂志,2021,50(6):946-948.[3]郭小双,尹泽刚,严冬梅.双联抗血小板联合不同剂量阿托伐他汀钙对急性脑梗塞患者血清MCP-1、VE-cadherin水平的影响[J].心血管康复医学杂志,2019,28(4):450-454.[4]张珊珊,王洪超.不同剂量阿托伐他汀治疗急性前循环脑梗死临床观察[J].中国药业,2020,29(22):91-93.[5]张芮娟.依达拉奉+阿托伐他汀钙治疗脑梗死的效果及对患者神经功能的影响[J].贵州医药,2021,45(11):1728-1729.[6]李伟,陈敏,宁波.阿托伐他汀联合阿司匹林治疗脑卒中的临床效果及对患者NIHSS评分的影响[J].重庆医学,2021,50(2):104-107.[7]孙田田,卢瑛,王丽,等.胞磷胆碱钠片治疗老年脑出血的临床观察[J].老年医学与保健,2021,27(6):1178-1181.[8]中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组.中国急性缺血性脑卒中诊治指南2018[J].中华神经科杂志,2018,51(9):666-682.[9]张丽,巩晓英,王继恒.阿托伐他汀联合氯吡格雷及拜阿司匹林对进展性脑梗死患者颈动脉粥样硬化的疗效评价[J].贵州医药,2019,43(12):1945-1947.[10]陈孔博,邵元.阿司匹林联合瑞舒伐他汀治疗老年短暂性脑缺血患者并发脑梗死的效果观察[J].实用临床医药杂志,2019,23(16):76-78.[11]郭强,张恒,翟洁敏,等.不同剂量阿托伐他汀联合依达拉奉对急性脑梗死患者血液流变学及神经功能的影响[J].解放军医药杂志,2019,31(5):59-62.[12]贺琦,米晓斌,王发荣.依达拉奉联合阿托伐他汀钙片对急性脑梗死患者颅内动脉血流动力学的影响[J].实用临床医药杂志,2019,23(1):44-47.[13]文洪波,黄健康,姚义琴,等.阿托伐他汀钙与匹伐他汀钙对急性脑梗死合并颈动脉粥样硬化斑块患者颈动脉斑块和血脂的影响[J].海南医学,2021,32(12):1541-1544.[14]孙万飞,于淑倩,王双艳,等.阿司匹林、氯吡格雷不同联合阿托伐他汀钙治疗对短暂缺血性脑缺血发作患者住院期间复发进展率的影响[J].中国医院药学杂志,2020,40(18):1974-1978.[15]董晓柳,徐士军,张秀清,等.阿托伐他汀对老年脑梗死病人TLR4信号通路及认知功能的影响[J].蚌埠医学院学报,2022,47(6):739-742.[16]朱静萍,张坤.脑梗死溶栓治疗前应用阿司匹林抗栓处理对促进患者闭塞血管再通的效果研究[J].中国急救复苏与灾害医学杂志,2020,15(7):807-809,831.[17]杨洪清,罗飏,马俊,等.阿司匹林与西洛他唑用于合并氯吡格雷抵抗老年急性脑梗死的二级预防效果比较[J].实用老年医学,2020,34(3):270-273.[18]曾宁,李才正,夏勇,等.胞磷胆碱钠片联合电脑认知功能系统训练对脑卒中认知功能障碍患者血清NPAS4、γ-GGT及ICAM-1的影响[J].临床和实验医学杂志,2022,21(22):2359-2363.[19]韩玉惠,杨雅玲,卢武生.丁苯酞氯化钠注射液联合胞磷胆碱钠注射液对老年脑梗死患者神经功能及JAK2/STAT3信号转导通路的影响[J].中国医院用药评价与分析,2020,20(3):304-307,311.[20]王亮,冯贺强,王欢.脑心通胶囊联合胞磷胆碱钠治疗急性脑梗死恢复期的临床研究[J].现代药物与临床,2020,35(12):2342-2346.[21]陈丽君,赵文杰,陈浩,等.胞磷胆碱钠胶囊联合尤瑞克林治疗急性脑梗死的效果及对血清Hcy、CRP水平的影响[J].中国现代医学杂志,2023,33(16):55-59.[22]李巧英,李胜刚,庞海英,等.利脑心片联合胞磷胆碱治疗急性脑梗死的临床研究[J].现代药物与临床,2023,38(9):2207-2211.[23]王婷,梁佳佳,薛亚妮.参芎葡萄糖与胞磷胆碱钠治疗老年高血压合并脑梗死及对血清趋化素、内脂素、血管性假血友病因子的影响[J].山西医药杂志,2021,50(19):2815-2818.[24]杨丽英,李红英.丁苯酞注射液联合胞磷胆碱钠治疗缺血性脑卒中的疗效及对患者认知功能的影响[J].海南医学,2021,32(7):835-839.

相似文献/References:

[1]刘海威.延续性护理对脑梗死运动功能障碍患者生活质量及社会支持的影响[J].医学信息,2018,31(02):160.[doi:10.3969/j.issn.1006-1959.2018.02.062]
　LIU Hai-wei.Effect of Continuous Nursing on Quality of Life and Social Support in Patients with Motor Dysfunction of Cerebral Infarction[J].Journal of Medical Information,2018,31(20):160.[doi:10.3969/j.issn.1006-1959.2018.02.062]
[2]韩艳庆,董 成,徐 玲.脑梗死并发急腹症诊治分析[J].医学信息,2018,31(06):188.[doi:10.3969/j.issn.1006-1959.2018.06.068]
　HAN Yan-qing,DONG Cheng,XU Ling.Analysis of Diagnosis and Treatment of Acute Cerebral Infarction Complicating Acute Abdominal Disease[J].Journal of Medical Information,2018,31(20):188.[doi:10.3969/j.issn.1006-1959.2018.06.068]
[3]王明远,陈海燕,张延朋,等.颈动脉斑块、血同型半胱氨酸及血尿酸对短暂性脑缺血 发作进程的影响研究[J].医学信息,2018,31(08):65.[doi:10.3969/j.issn.1006-1959.2018.08.020]
　WANG Ming-yuan,CHEN Hai-yan,ZHANG Yan-peng,et al.Effects of Carotid Plaque,Homocysteine and Serum Uric Acid on Transient Ischemic Attack[J].Journal of Medical Information,2018,31(20):65.[doi:10.3969/j.issn.1006-1959.2018.08.020]
[4]甘雪梅.系统护理对脑梗死患者生活质量及满意度的影响[J].医学信息,2018,31(08):172.[doi:10.3969/j.issn.1006-1959.2018.08.062]
　GAN Xue-mei.Effect of Systematic Nursing on Quality of Life and Satisfaction of Patients with Cerebral Infarction[J].Journal of Medical Information,2018,31(20):172.[doi:10.3969/j.issn.1006-1959.2018.08.062]
[5]单 敏,常燕燕,赵大鹏,等.急性前循环脑梗死患者梗死体积与 血清NSE水平相关性研究[J].医学信息,2018,31(10):1.[doi:10.3969/j.issn.1006-1959.2018.10.001]
　SHAN Min,CHANG Yan-yan,ZHAO Da-peng,et al.Correlation between Infarct Volume and Serum NSE Level in Patients with Acute Anterior Circulation Cerebral Infarction[J].Journal of Medical Information,2018,31(20):1.[doi:10.3969/j.issn.1006-1959.2018.10.001]
[6]李福滔,张素平.单侧颈内动脉夹层致脑梗死1例报道[J].医学信息,2018,31(11):191.[doi:10.3969/j.issn.1006-1959.2018.11.065]
[7]张怀祥,段晓宇.脑梗死后认知障碍的病理学机制、相关危险因素及治疗[J].医学信息,2018,31(16):21.[doi:10.3969/j.issn.1006-1959.2018.16.007]
　ZHANG Huai-xiang,DUAN Xiao-yu.Pathological Mechanism,Related Risk Factors and Treatment of Cognitive Impairment after Cerebral Infarction[J].Journal of Medical Information,2018,31(20):21.[doi:10.3969/j.issn.1006-1959.2018.16.007]
[8]柳 星,卢会琴.脑梗死恢复期的临床路径实施效果分析[J].医学信息,2018,31(19):128.[doi:10.3969/j.issn.1006-1959.2018.19.038]
　LIU Xing,LU Hui-qin.Analysis of Clinical Path Implementation in the Recovery Period of Cerebral Infarction[J].Journal of Medical Information,2018,31(20):128.[doi:10.3969/j.issn.1006-1959.2018.19.038]
[9]杜 敏.血清小而密低密度脂蛋白胆固醇检测对预测脑梗死患者预后评估的价值[J].医学信息,2019,32(10):173.[doi:10.3969/j.issn.1006-1959.2019.10.058]
　DU Min.The Value of Serum Small,Dense Low-density Lipoprotein Cholesterol Test in Predicting the Prognosis of Patients with Cerebral Infarction[J].Journal of Medical Information,2019,32(20):173.[doi:10.3969/j.issn.1006-1959.2019.10.058]
[10]陈 曦,寇 天.阿托伐他汀钙片治疗脑卒中并脑微出血的临床研究[J].医学信息,2019,32(15):147.[doi:10.3969/j.issn.1006-1959.2019.15.048]
　CHEN Xi,KOU Tian.Clinical Study of Atorvastatin Calcium Tablets in the Treatment of Stroke and Cerebral Microhemorrhage[J].Journal of Medical Information,2019,32(20):147.[doi:10.3969/j.issn.1006-1959.2019.15.048]

更新日期/Last Update: 1900-01-01